Ellevest Inc’s Trueblue TBI Stock Holding History

Ellevest Inc’s Portfolio TBI Stock Details TBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-3	Closed	-$59	–	2059
2022 Q4	$59	Buy	+3	New	+$61	﹤0.01%	1784

Other funds holding TBI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Ellevest Inc's TBI Position: Q1 2023 in Review

Ellevest Inc sold out of Trueblue (TBI) in Q1 2023, closing a stake of 3 shares — an estimated $59 sold.

Ellevest Inc first reported a position in TBI in Q4 2022 and held it in 1 quarter. The position peaked at $59 in Q4 2022. 156 funds tracked by Wall St. Rank hold TBI as of Q1 2023.

Ellevest Inc reported no remaining Trueblue position as of Q1 2023 after selling out during the quarter.
Ellevest Inc sold 3 Trueblue shares in Q1 2023, an estimated $59.
Ellevest Inc first reported a position in Trueblue in Q4 2022 and held it in 1 quarter.
Ellevest Inc's Trueblue position peaked at $59 in Q4 2022.
156 funds tracked by Wall St. Rank held Trueblue as of Q1 2023.

Based on Ellevest Inc's 13F filing for Q1 2023, filed 4 May 2023.